Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)

This study is currently recruiting participants.
Verified January 2012 by Columbia University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Columbia University
ClinicalTrials.gov Identifier:
NCT00104585
First received: March 1, 2005
Last updated: January 18, 2012
Last verified: January 2012

March 1, 2005
January 18, 2012
July 2004
September 2012   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00104585 on ClinicalTrials.gov Archive Site
 
 
 
 
 
Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)
Genetic Epidemiology of Parkinson's Disease

The purpose of this study is to investigate genetic and environmental risk factors that increase susceptibility to the development of early-onset Parkinson's disease (developed at or before age 50).

Parkinson's disease (PD) is a common, neurodegenerative condition. Although mostly a late-onset disorder, 10 percent of people with PD are reported to develop symptoms before the age of 50. To date, six genes have been found to be associated with PD, however the majority have been found in rare PD 'families'. Some studies have also identified a number of environmental risk factors, such as pesticide use, that appear to increase the risk of PD.

In a previous study, Dr. Karen Marder and her research team found that close family members of people with both early- and late-onset PD have a three-fold increased risk of PD compared to close family members of people without PD.

The purpose of the Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) study is to identify the genetic factors that contribute to the development of early-onset Parkinson's disease, and to understand how these genetic factors interact with other genes and the environment to cause PD.

Participation in the study involves a blood draw (to look for genetic factors associated with PD), questionnaires collecting information on family and medical history, and a neurological examination. In addition participants may be contacted in the future and asked to participate in a more detailed interview. At that time, study investigators will also ask participants for permission to contact family members to invite them to participate in the study.

This research study requires participants to sign a consent form, which states that the research is voluntary and confidential. In addition, since this is a research study, genetic results are not released to participants or their family members now or in the future.

Scientists hope this multi-center study will increase the current knowledge of PD and that the identification of factors that cause PD will lead to better diagnosis and treatment.

Observational
Observational Model: Family-Based
Time Perspective: Cross-Sectional
Retention:   Samples With DNA
Description:

whole blood

Non-Probability Sample

Young onset PD patients

Parkinson's Disease
 
1
People with young onset Parkinson's disease and their family members
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
800
 
September 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Any person with Parkinson's disease in the United States whose symptoms began at age 50 or younger and was diagnosed by a neurologist.
Both
18 Years and older
No
Contact: Helen Mejia-Santana, M.A. 877-305-2438 research@corepdstudy.org
United States
 
NCT00104585
AAAA5609, R01NS036630
No
Columbia University
Columbia University
National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator: Karen Marder, M.D., M.PH. Columbia University
Columbia University
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP